Skip to main content

Table 1 Characteristics of the study population

From: Assessing patients’ characteristics and treatment patterns among children with atopic dermatitis

Characteristics (n = 867)

Age (years)

5.9 ± 3.6

Females

438 (50.5%)

SCORAD:

 0–15

357 (41.2%)

 16–30

237 (27.3%)

 31–40

141 (16.3%)

 41–60

91 (10.5%)

  > 60

41 (4.7%)

Age of onset

  < 2 months

229 (26.4%)

 2–6 months

242 (27.9%)

 7–12 months

154 (17.8%)

 13–36 months

149 (17.2%)

  > 36 months

93 (10.7%)

History of AD in first-grade relatives

35 (4.0%)

Exposure to passive smoking

134 (15.5%)

Reported inhalant allergy

199 (23.0%)

Reported food allergy

82 (9.5%)

Therapies in the last month:

 Emollients

478 (55.1%)

 TCS

396 (45.7%)

 1–5 days/month

120 (13.8%)

 6–10 days/month

116 (13.4%)

  > 10 days/month

160 (18.5%)

 TCI

39 (4.5%)

 Oral steroids

55 (6.3%)

  1. Data were represented as N (%) or mean ± standard deviation
  2. AD atopic dermatitis, SCORAD SCOring Atopic Dermatitis, TCI topical calcineurin inhibitors TCS topical corticosteroids